APHL, with funding support from the Centers for Disease Control and Prevention (CDC) is pleased to offer funds to one state, local or territorial laboratory to conduct serum PFAS testing for individuals whose results could provide or clarify critical scientific information, as determined in consultation with CDC and the Agency for Toxic Substances and Disease Registry (ATSDR).
State, local, or territorial laboratories with Clinical Laboratory Improvement Amendments (CLIA) certification are eligible to submit proposals. Interested parties must submit a proposal to APHL that provides all of the information specified in the
Requirements section below. In order to meet consideration requirements, applicants must complete proposals no later than the Proposed Due Date specified in the
Anticipated RFP Schedule section below. Applicants will find proposal submission information in the
Response Submittal section below.
Anticipated RFP Schedule
Applications are due to firstname.lastname@example.org by 5:00 pm Eastern Standard Time (EST) on March 17, 2020. APHL anticipates the following schedule for the entire competitive bidding process:
March 10, 2020 APHL Issues RFP
March 24, 2020 Complete proposals due to email@example.com by 5:00 pm EST
March 25, 2020 Proposal Review
April 8, 2020 APHL posts names of the selected applicant(s) to procurement site,
If APHL makes any modification to this anticipated schedule, it will post the change to APHL's procurement site,
APHL must receive a complete proposal by no later than
5:00 pm EST on March 24, 2020. Applicants must send proposals via email to
APHL will send an email acknowledging the receipt of your proposal. If you do not receive an acknowledgement within 72 hours, please email
firstname.lastname@example.org to confirm receipt.
APHL will award one sub-award of $19,000, payable in two installments, to a single awardee laboratory. APHL will email a notice of award to the selected awardee laboratory. The selected awardee laboratory will receive funding through a sub-award agreement with APHL.
Official RFP Document will provide detailed information in regards to this request, please read it on its entirety. Please direct all questions regarding this RFP or its requirements via email to Erin Morin at
email@example.com with a copy to Julianne Nassif at
Questions and Answers
Is this an award or a cost-reimbursement contract? The mention of the $200/test is confusing.
A: This is a sub-award to the recipient from APHL. The $200/sample price was included to estimate the maximum number of analyses (n=95) expected to be completed as part of this project.
Who will identify individuals to be tested?
A: Partners at the Agency for Toxic Substances and Disease Registry (ATSDR) will determine the individuals to be tested. ATSDR and APHL will work with the awardee to facilitate specimen collection and transport.
Who will order the test?
A: In order to comply with CLIA requirements, ATSDR will identify a medical professional who will order the tests and to whom test results will be reported.